Sumeska Thavarajah
Dr. Sumeska Thavarajah is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine.She earned her M.D. at Wayne State University School of Medicine in Detroit, MI.She completed her internal medicine residency at the University of Connecticut Health Center in Farmington, CT.Dr. Thavarajah came to Baltimore, MD to pursue her nephrology fellowship at Johns Hopkins Bayview Medical Center, where she has served as faculty since 2005.Dr. Thavarajah is committed to education.She was the program director of the Johns Hopkins Bayview Nephrology Fellowship prior to its merger with Johns Hopkins Hospital Nephrology Fellowship in 2012.She is dedicated to bringing community awareness on kidney disease through her work with the National Kidney Foundation serving Maryland and Delaware.Dr. Thavarajah has served as the Chairman of its Medical Advisory Board for the last six years and has served on the board since 2012. She has worked on development of patient education programs for focusing on dialysis options and transplant options.She has been honored with NKF-MD’s Linda Cameron Award for Patient Services for donating her time at community health screenings and assisting the Programs & Advocacy committee.Dr. Thavarajah joined the BMC Nephrology editorial board in October 2019 as a Blog Editor for the journal.
Could Arteriovenous Fistula Creation be Reno-Protective?
This week in BMC Nephrology, an article by Benard et al. associated the creation of arteriovenous fistulas with a reduction in the decline of glomerular filtration rate in pre-dialysis patients. In our first BMC Nephrology blog, Dr. Sumeska Thavarajah explores the potential reno-protective effects of arteriovenous fistulas beyond their primary role as a vascular access.
Advanced vascular access planning and use of an AVF versus a tunneled catheter has previously been associated with better outcomes and less mortality.
A large proportion of time in late chronic kidney disease (CKD) care is devoted to dialysis preparation and, for those pursuing hemodialysis, establishment of a vascular access. Arteriovenous fistulas (AVFs) are considered the gold standard given their longevity and lower risk of infection. Guidelines from Kidney Disease Improving Global Outcomes (KDIGO) and international nephrology societies advocate for advanced planning for dialysis vascular access, including the consideration of preserving arm veins, vein mapping prior to surgery, and early referral for vascular surgery. Advanced vascular access planning and use of an AVF versus a tunneled catheter has previously been associated with better outcomes and less mortality.
.png)
No hay comentarios:
Publicar un comentario